During Friday’s Current trade, Shares of Global Cash Access Holdings, Inc. (NYSE:GCA), lost -2.03% to $5.32.
Global Cash Access Holdings, Inc. (GCA) declared that the Company’s corporate name will change to Everi Holdings Inc. effective August 24, 2015. The organization-wide rebranding, together with the Company’s new logo and new corporate name, reflect the Company’s successful transition to a full-service casino gaming equipment and payment solutions provider focusing on a broad range of opportunities to address customers’ casino floor and technology needs. Concurrent with the August 24, 2015 name change, the Company will start to trade under a new ticker symbol, “EVRI”, on the New York Stock Exchange. To highlight the re-branding effort and celebrate the new ticker symbol, Company representatives will ring the opening bell at the New York Stock Exchange on August 24, 2015.
Global Cash Access Holdings, Inc. provides cash access services and related equipment and services to the gaming industry. The company operates in Cash Advance, ATM, Check Services, Games, and Other segments. Its cash access products and services comprise Casino Cash Plus 3-in-1 ATM, a cash-dispensing machine that offers patrons to access cash through ATM cash withdrawals, point-of-sale (POS) debit card transactions, and credit card cash access transactions.
Shares of Ceragon Netoperates Ltd (NASDAQ:CRNT), inclined 3.55% to $1.46, during its current trading session.
Ceragon Netoperates Ltd. (CRNT), the #1 wireless backhaul specialist recently stated results for the second quarter which ended June 30, 2015.
Second Quarter 2015 Highlights:
Revenues - $94.8 million, up 4.8% from the second quarter of 2014, and up 1.2% from the first quarter of 2015.
Gross margin - 28.2%, contrast to 26.3% in the second quarter of 2014 and 25.9% in the first quarter of 2015.
Operating income - $5.9 million, contrast to $11.8 million in the second quarter of 2014, which comprised of $16.8 million of non-recurring other income, and contrast to $0.6 million in the first quarter of 2015.
Net income (loss) – Net income of $1.3 million, or $0.02 per diluted share for the second quarter of 2015. Net income for the second quarter of 2014, counting non-recurring other income, was $8.0 million, or $0.15 per diluted share. Net loss for the first quarter of 2015 was $(7.0) million or $(0.09) per diluted share.
Ceragon Netoperates Ltd. provides wireless backhaul solutions that enable cellular operators and other wireless service providers to deliver voice and data services worldwide. Its wireless backhaul solutions use microwave technology to transfer telecommunication traffic between base stations, small sells, and the core of the service providers network.
Abbott Laboratories (NYSE:ABT), during its Friday’s current trading session gained 0.34% to $50.01.
Abbott (ABT) declared that it has reached a contract to purchase Tendyne Holdings, Inc., a private medical device company focused on developing minimally invasive mitral valve replacement therapies. Under the terms of the agreement, Abbott will acquire the equity of Tendyne that it does not already own for $225 million upfront, resulting in a total transaction value of $250 million, plus potential future payments tied to regulatory milestones.
Tendyne’s Bioprosthetic Mitral Valve System is an investigational device and not presently accessible for sale. The U.S. Food and Drug Administration has offered approval for a feasibility clinical trial to provide data about the device’s safety and effectiveness. The trial has begun enrolling patients, and there are plans to start enrollment next year in a clinical trial to support CE Mark in Europe.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon.
Finally, Limelight Netoperates, Inc. (NASDAQ:LLNW), gained 1.12%, to $2.70.
Limelight Netoperates, Inc. (LLNW), a global leader in digital content delivery, recently stated revenue of $43.8 million for the second quarter ended June 30, 2015, contrast to $41.3 million in the second quarter of 2014, an enhance of six percent.
During the second quarter of 2014, revenue from Netflix was $5.4 million. Revenue was also negatively influenced in the second quarter of 2015 by changes in foreign currency of about $1.0 million. Adjusting for the impact of these items, revenue raised by 25 percent period over period and 4 percent sequentially.
GAAP gross margins were 41.4% in the second quarter of 2015, up 300 basis points from 38.4% in the second quarter of 2014. Effective April 1, 2015, we reorganized job responsibilities of certain employees from cost of services to research and development, on a prospective basis. This reorganization resulted in about $0.75 million, or 170 basis points, of improvement in gross margin period over period.
Limelight Netoperates, Inc. provides content delivery network services to deliver digital content over the Internet in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers the Orchestrate Platform, a suite of integrated services, which comprise content delivery services, video content administration services, performance services for Website and Web application acceleration, and cloud storage services for various devices. It also offers professional services and other infrastructure services, such as transit and rack space services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
